Vanguard Group
GRTS

Vanguard Group’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Vanguard Group’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,643,928
Closed -$2.69M – 4364
2024
Q3 		$2.69M Hold
4,643,928
– – ﹤0.01% 3464
2024
Q2 		$2.87M Sell
4,643,928
-89,863
-2% -$75.9K ﹤0.01% 3457
2024
Q1 		$12.2M Buy
4,733,791
+317,499
+7% +$776K ﹤0.01% 2852
2023
Q4 		$9.01M Buy
4,416,292
+358,075
+9% +$654K ﹤0.01% 3008
2023
Q3 		$6.98M Buy
4,058,217
+9,215
+0.2% +$16.4K ﹤0.01% 3103
2023
Q2 		$7.9M Buy
4,049,002
+388,103
+11% +$909K ﹤0.01% 3080
2023
Q1 		$10.2M Buy
3,660,899
+474,593
+15% +$1.36M ﹤0.01% 2928
2022
Q4 		$11M Buy
3,186,306
+81,330
+3% +$232K ﹤0.01% 2914
2022
Q3 		$7.98M Buy
3,104,976
+184,692
+6% +$588K ﹤0.01% 3072
2022
Q2 		$7.07M Buy
2,920,284
+185,577
+7% +$487K ﹤0.01% 3185
2022
Q1 		$11.3M Buy
2,734,707
+23,437
+0.9% +$124K ﹤0.01% 3085
2021
Q4 		$34.9M Buy
2,711,270
+742,246
+38% +$8.22M ﹤0.01% 2545
2021
Q3 		$21.3M Buy
1,969,024
+545,775
+38% +$4.97M ﹤0.01% 2829
2021
Q2 		$13M Buy
1,423,249
+239,650
+20% +$2.22M ﹤0.01% 3075
2021
Q1 		$11.2M Buy
1,183,599
+358,232
+43% +$4.93M ﹤0.01% 3091
2020
Q4 		$3.25M Sell
825,367
-197,732
-19% -$598K ﹤0.01% 3529
2020
Q3 		$2.71M Sell
1,023,099
-47,466
-4% -$176K ﹤0.01% 3397
2020
Q2 		$7.11M Buy
1,070,565
+32,281
+3% +$217K ﹤0.01% 2922
2020
Q1 		$6.04M Sell
1,038,284
-515
-0% -$4.32K ﹤0.01% 2881
2019
Q4 		$9.32M Sell
1,038,799
-3,489
-0.3% -$29.1K ﹤0.01% 2891
2019
Q3 		$9M Buy
1,042,288
+70,917
+7% +$716K ﹤0.01% 2871
2019
Q2 		$10.8M Buy
971,371
+639,906
+193% +$7.32M ﹤0.01% 2812
2019
Q1 		$4.41M Buy
331,465
+1,556
+0.5% +$20.8K ﹤0.01% 3185
2018
Q4 		$5.1M Buy
329,909
+255,295
+342% +$4.87M ﹤0.01% 3081
2018
Q3 		$1.06M Buy
+74,614
New +$1.06M ﹤0.01% 3704

Other funds holding GRTS

BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Vanguard Group's GRTS Position: Q4 2024 in Review

Vanguard Group sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 4,643,928 shares — an estimated $2.69M sold.

Vanguard Group first reported a position in GRTS in Q3 2018 and held it in 25 quarters. The position peaked at $34.9M in Q4 2021. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.

  • Vanguard Group reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Vanguard Group sold 4,643,928 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $2.69M.
  • Vanguard Group first reported a position in Gritstone bio, Inc. Common Stock in Q3 2018 and held it in 25 quarters.
  • Vanguard Group's Gritstone bio, Inc. Common Stock position peaked at $34.9M in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.

Based on Vanguard Group's 13F filing for Q4 2024, filed 11 Feb 2025.